A5044023797- Systemic Lupus Erythematosus Research
- Systemic Sclerosis and Related Diseases
- Salivary Gland Disorders and Functions
- Monoclonal and Polyclonal Antibodies Research
- Vasculitis and related conditions
- Rheumatoid Arthritis Research and Therapies
- Otitis Media and Relapsing Polychondritis
- Ocular Diseases and Behçet’s Syndrome
- Atherosclerosis and Cardiovascular Diseases
- Pregnancy and Medication Impact
- Urticaria and Related Conditions
- Autoimmune and Inflammatory Disorders Research
- T-cell and B-cell Immunology
- Liver Diseases and Immunity
- Salivary Gland Tumors Diagnosis and Treatment
- Renal Diseases and Glomerulopathies
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- COVID-19 Clinical Research Studies
- Reproductive System and Pregnancy
- Psoriasis: Treatment and Pathogenesis
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Connective Tissue Growth Factor Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Pregnancy and preeclampsia studies
University of Pisa
2015-2024
Azienda Ospedaliera Universitaria Pisana
2019-2024
Center for Rheumatology
2017-2024
University of Ferrara
2021-2024
Marche Polytechnic University
2024
University of Siena
2019-2023
University of Perugia
2020
Assistance Publique – Hôpitaux de Paris
2018
BioCruces Health research Institute
2018
University of the Basque Country
2018
To evaluate the proportion of patients who have successfully withdrawn glucocorticoids (GCs) in a longitudinal cohort with systemic lupus erythematosus (SLE) over period 6 years; to patient characteristics during GC withdrawal relation existing definitions remission and Lupus Low Disease Activity State (LLDAS); occurrence flares after withdrawal.Patients attempted were identified for cohort, following information was assessed attempts: date last disease flare, activity damage ongoing...
Fatigue is prevalent in people with inflammatory rheumatic and musculoskeletal diseases (I-RMDs) recognised as one of the most challenging symptoms to manage. The existence multiple factors associated driving maintaining fatigue, evidence about what improves fatigue has led a multifaceted approach its management. However, there are no recommendations for management I-RMDs. This lack guidance those living health professionals delivering clinical care. Therefore, our aim was develop EULAR
To investigate pregnancy outcomes in women with autoimmune rheumatic diseases (ARD) the Italian prospective cohort study P-RHEUM.it.
Objective: Neonatal Lupus (NL) is a rare syndrome caused by placental transfer of maternal anti-SSA/Ro and anti-La/SSB autoantibodies to the fetus. The rarity this condition requires establishment multidisciplinary registries in order improve our knowledge. Method: Inclusion criteria retrospective study were confirmed positivity for and/or anti-SSB/La antibodies, presence II or III degree congenital heart block (CHB) utero neonatal period (up 30 days after birth). Result: Eighty-nine cases...
To determine whether disease remission or low activity state at the beginning of pregnancy in SLE patients is associated with better outcome.Pregnancies prospectively monitored by clinics four rheumatology centres were enrolled. Patient demographics and clinical information collected baseline (pregnancy visit before 8 weeks gestation) including according to Definition Remission (DORIS) criteria and/or Lupus Low Disease Activity State (LLDAS). Univariate multivariate analysis performed...
SLE is an autoimmune disease that predominantly affects women. As most epidemiological and interventional studies are on populations with a clear female prevalence, the influence of gender in course, drug response damage accrual yet to be fully explored comprehended.To describe differences comorbidities, use medications long-term outcomes large cohort patients SLE.Retrospective gender-based analysis prospectively collected data from monocentric Caucasian at least 1 year follow-up.417 were...
Fatigue is a very common and debilitating symptom in patients with systemic lupus erythematosus (SLE), even among those mild or inactive disease. The objective of this study to define fatigue determinants describe the impact on health-related quality life (HRQoL) illness perception monocentric cohort SLE. This cross-sectional study. Adult SLE were included. For each patient, demographics, medications, comorbidities, organ damage (Systemic Lupus International Collaborating Clinics Damage...
This case report describes 2 women with severe and refractory discoid lupus erythematosus that was treated anifrolumab.